| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | Chief Medical Officer | Common Stock | 166K | $331K | $1.99 | Jul 10, 2025 | Direct |
| C4 Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 131K | Feb 14, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | Jul 10, 2025 | 2 | -$14.7K | 4/A | Jul 15, 2025 | Chief Medical Officer |
| CCCC | C4 Therapeutics, Inc. | Feb 14, 2025 | 3 | -$16.4K | 4 | Feb 18, 2025 | Chief Medical Officer |
| CCCC | C4 Therapeutics, Inc. | Jul 10, 2024 | 1 | -$31K | 4 | Jul 11, 2024 | Chief Medical Officer |
| CCCC | C4 Therapeutics, Inc. | Feb 14, 2024 | 2 | $0 | 4 | Feb 15, 2024 | Chief Medical Officer |
| CCCC | C4 Therapeutics, Inc. | Jul 10, 2023 | 2 | $0 | 4 | Jul 12, 2023 | Chief Medical Officer |
| CCCC | C4 Therapeutics, Inc. | Jul 10, 2023 | 0 | $0 | 3 | Jul 12, 2023 | Chief Medical Officer |